References
- WongFYReassortant highly pathogenic influenza A (H5N6) virus in LaosEmerg. Infect. Dis.201521 511 51610.3201/eid2103.1414884344285
- WuHNovel reassortant highly pathogenic H5N6 avian viruses in poultry in ChinaInfect. Genet. Evol.201531646710.1016/j.meegid.2015.01.019
- NguyenDTShifting clade distribution, reassortment, and emergence of new subtypes of highly pathogenic avian influenza A(H5) viruses collected from Vietnamese poultry from 2012 to 2015J. Virol.201791e01708e0171610.1128/JVI.01708-165309939
- KimHKJeongDGYoonSWRecent outbreaks of highly pathogenic avian influenza viruses in South KoreaClin. Exp. Vaccin. Res201769510310.7774/cevr.2017.6.2.95
- World Health Organization. Monthly Risk Assessment Summary; 30 Oct 2017. [accessed 23 Nov 2017]. http://www.who.int/influenza /human_animal_interface/Influenza_Summary_IRA_HA_interface_10_30_2017.pdf?ua=1
- World Health Organization. Influenza at the human-animal interface. Summary and assessment, 30 October to 7 December 2017. http://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface_12_07_2017.pdf?ua=1
- BiYGenesis, evolution and prevalence of H5N6 avian influenza viruses in ChinaCell Host Microbe20162081082010.1016/j.chom.2016.10.022
- YangZFHuman infection with a novel avian influenza A (H5N6) virusN. Engl. J. Med.201537348748910.1056/NEJMc1502983
- ZhouBZhongNGuanYTreatment with convalescent plasma for influenza A (H5N1) infectionN. Engl. J. Med.20073571450145110.1056/NEJMc070359
- HungIFConvalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infectionClin. Infect. Dis.20115244745610.1093/cid/ciq106
- PanMHuman infection with a novel, highly pathogenic avian influenza A (H5N6)virus: virological and clinical findingsJ. Infect.201672525910.1016/j.jinf.2015.06.009
- XuWA fatal case of infection with a further reassortant, highly pathogenic avian influenza (HPAI) H5N6 virus in Yunnan, ChinaInfect. Genet. Evol.201640636610.1016/j.meegid.2016.02.020
- LuXA mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humansJ. Virol.19997359035911112651
- BelserJAPathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and miceNature201350155655910.1038/nature12391
- ZhaoZAvian influenza H5N6 viruses exhibit differing pathogenicities and transmissibilities in mammalsSci. Rep.2017710.1038/s41598-017-16139-15701206
- PengXAmino acid substitutions occurring during adaptation of an emergent H5N6 avian influenza virus to mammalsArch. Virol.201616111651170
- ZhangCAmino acid substitutions associated with avian H5N6 influenza A virus adaptation to miceFront. Microbiol.20178176310.3389/fmicb.2017.017635605651
- SangXRapid emergence of a PB2-E627K substitution confers a virulent phenotype to an H9N2 avian influenza virus during adoption in miceArch. Virol.20151601267127710.1007/s00705-015-2383-5
- ChengKPB2-E627K and PA-T97I substitutions enhance polymerase activity and confer a virulent phenotype to an H6N1 avian influenza virus in miceVirologoy2014468-47020721310.1016/j.virol.2014.08.010
- MokCKGenetic characterization of highly pathogenic avian influenza A (H5N6) virus, Guangdong, ChinaEmerg. Infect. Dis.2015212268227110.3201/eid2112.1508094672456
- BelserJAPathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in miceJ. Virol.2010844194420310.1128/JVI.02742-092863721
- de JongMDFatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemiaNat. Med.2006121203120710.1038/nm14774333202
- PeirisJSRe-emergence of fatal human influenza A subtype H5N1 diseaseLancet200436361761910.1016/S0140-6736(04)15595-5
- ChiYCytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in ChinaJ. Infect. Dis.20132081962196710.1093/infdis/jit440
- ChenYHuman infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genomeLancet20133811916192510.1016/S0140-6736(13)60903-4
- SzretterKJRole of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in miceJ. Virol.2007812736274410.1128/JVI.02336-06
- MokCKPathogenicity of the novel A/H7N9 influenza virus in miceMBio20134e003621310.1128/mBio.00362-133705449
- ZhaoGDifferences in the pathogenicity and inflammatory responses induced by avian influenza A/H7N9 virus infection in BALB/c and C57BL/6 mouse modelsPLoS ONE20149e9298710.1371/journal.pone.00929873968029
- MooreKWde Waal MalefytRCoffmanRLO’GarraAInterleukin-10 and the interleukin-10 receptorAnnu. Rev. Immunol.20011968376510.1146/annurev.immunol.19.1.683
- SunJEffector T cells control lung inflammation during acute influenza virus infection by producing IL-10Nat. Med.20091527728410.1038/nm.19292693210
- MosconaANeuraminidase inhibitors for influenzaN. Engl. J. Med.20053531363137310.1056/NEJMra050740
- SatpathyDMSahuTBeheraTREquine rabies immunoglobulin: a study on its clinical safetyJ. Indian Med. Assoc.2005103238
- LangJEvaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, vero-cell rabies vaccineActa Trop.19987031733310.1016/S0001-706X(98)00038-2
- LuJPassive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F (ab’)2 in miceRespir. Res.20067435010.1186/1465-9921-7-431459145
- MengWRapid generation of human-like neutralizing monoclonal antibodies in urgent preparedness for influenza pandemics and virulent infectious diseasesPLoS ONE20138e6627610.1371/journal.pone.00662763688872
- PanWInduction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primatesAntiviral Res.20141071510.1016/j.antiviral.2014.04.003
- PanWQImprovement of influenza vaccine strain A/Viernam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34Hum. Vaccin. Immunother.201281810.4161/hv.18468
- Laemmli UK.Cleavage of structural proteins during the assembly pf bacteriophage T4Nature197022768068510.1038/227680a0
- Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza2011Geneva, SwitzerlandWHO Press
- RoweTDetection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assaysJ. Clin. Microbiol.19993793794388628
- ReedLJMuenchMA simple method for estimating fifty percent endpointsAm. J. Hyg.193827493497